Co-treatment of HCC cell lines with recombinant TRAIL and Bortezomib (as proteasome inhibitors) increased the apoptosis induction in the Huh7 cells, compared to the primary hepatocytes [159]. The gene discussed is TNFSF10; the disease is hepatocellular carcinoma.